iKnowMed Electronic Health Record System (EHR), the highest-ranked web-based oncology-specific EHR by Black Book Rankings and a product of McKesson Specialty Health Solutions for Oncology, was included in the new KLAS report Oncology IS 2011: Integrating the Island. In the report, iKnowMed scored an 85 overall performance score, more than three points higher than it scored in The Oncology IT Balancing Act: Integration vs. Functionality published by KLAS in 2010; due to a small open market customer sample size, the EHR’s KLAS rank could not be included in the report.
“Although not fully ranked, iKnowMed scored an impressive 85 overall on the KLAS scale,” said Monique Rasband, author of the KLAS report. “Since 2010, this product has really made its mark on the industry by more than doubling the number of practices in the open market. Plus, providers are all abuzz about what iKnowMed may be able to offer in the future, especially because of the recent initial rollout of this product’s tight integration with Lynx Mobile, McKesson Specialty Health’s leading drug inventory management system. This could make newcomer McKesson Specialty Health (published under US Oncology in the 2011 KLAS report) a formidable competitor in the oncology IT space.”
Compared to the 2010 KLAS report, iKnowMed scores either increased or maintained status quo across 19 of the 25 categories. Results for the Sales & Contracting, Ease of Use and Implementation & Training, among other categories, increased across the board when compared to 2010 results.
“iKnowMed’s nimbleness combined with a web-based platform makes it less expensive, easier to use, and allows them to execute quick upgrades,” said Rasband. “These aspects of the product have made iKnowMed more attractive to providers.”
“We’re excited to see the continued increase in customer satisfaction of iKnowMed,” said Asif Ahmad, senior vice president, Information and Technology Services, McKesson Specialty Health. “We’ve dedicated a lot of time and resources to upgrades and recent rollouts. We’re pleased to know that our customers are happy with the changes. We remain committed to making iKnowMed EHR the best, most innovative product in community oncology practices today.”
iKnowMed is a web-based oncology-specific EHR that has achieved Complete Certification for Stage 1 Meaningful Use. Clinical content includes point-of-care decision support with detailed cancer diagnosis and staging content, and a cancer regimen library of more than 400 protocols. iKnowMed EHR supports clinical trial accruals for new and existing patients, provides access to evidence-based pathways, has integrated ePrescribing capabilities, a charge interface, and has been proven to improve gross charge capture ranging from $35,000 to $86,000 per oncologist.